Regulatory14 Aug 2026, 09:50 pm
EBIX Ltd: Deviation in Utilization of Preferential Issue Proceeds
AI Summary
EBIX Ltd has reported a deviation in the utilization of funds raised from a preferential issue of Compulsorily Convertible Warrants. The monitoring agency, CARE Ratings Limited, noted that ₹46.15 crore was transferred towards working capital requirements of the company and its subsidiaries, step-down subsidiaries, joint ventures, and associate entities. Specifically, ₹41.65 crore went to Ebix Travels Limited, ₹2.23 crore to Ebix Technologies Limited, and ₹2.27 crore to Vikas Lifecare Limited. The agency has not received sufficient documentation to assess the working capital utilization in these entities. The deviation falls within the 10-25% range.
Key Highlights
- EBIX Ltd reported deviation in preferential issue proceeds utilization.
- ₹46.15 crore transferred to working capital of group entities.
- Documentation for working capital use in subsidiaries is insufficient.
- Deviation falls within the 10-25% range as per CARE Ratings.
- Monitoring agency report submitted for quarter ended June 30, 2026.
Price Impact
More from EBIX